Corrigendum: Immune celllipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis .

MLA

Wei Zhang, et al. “Corrigendum: Immune Celllipoprotein Imbalance as a Marker for Early Diagnosis of Non-Small Cell Lung Cancer Metastasis .” Frontiers in Oncology, vol. 12, Dec. 2022, p. 1. EBSCOhost, https://doi.org/10.3389/fonc.2022.1118042.

APA

Wei Zhang, Weiwei Wang, Junlu Wu, Jiale Tian, Wenhui Yan, Yi Yuan, Yiwen Yao, Anquan Shang, & Wenqiang Quan. (2022). Corrigendum: Immune celllipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis . Frontiers in Oncology, 12, 1. https://doi.org/10.3389/fonc.2022.1118042

Chicago

Wei Zhang, Weiwei Wang, Junlu Wu, Jiale Tian, Wenhui Yan, Yi Yuan, Yiwen Yao, Anquan Shang, and Wenqiang Quan. 2022. “Corrigendum: Immune Celllipoprotein Imbalance as a Marker for Early Diagnosis of Non-Small Cell Lung Cancer Metastasis .” Frontiers in Oncology 12 (December): 1. doi:10.3389/fonc.2022.1118042.